Robert A. Squire

2.8k total citations
47 papers, 2.1k citations indexed

About

Robert A. Squire is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert A. Squire has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert A. Squire's work include Carcinogens and Genotoxicity Assessment (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Robert A. Squire is often cited by papers focused on Carcinogens and Genotoxicity Assessment (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Robert A. Squire collaborates with scholars based in United States, Netherlands and Canada. Robert A. Squire's co-authors include Morton Levitt, Michael B. Sporn, Charles Brown, Dawn G. Goodman, John D. Strandberg, Joseph M. Smith, Martin L. Wenk, Kenneth C. Chu, Joel Ward and Mette Strand and has published in prestigious journals such as Science, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Robert A. Squire

47 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Squire United States 23 669 453 259 244 243 47 2.1k
Martin L. Wenk United States 23 913 1.4× 461 1.0× 272 1.1× 340 1.4× 295 1.2× 55 1.9k
S. W. B. Ewen United Kingdom 26 901 1.3× 267 0.6× 228 0.9× 140 0.6× 246 1.0× 82 2.3k
P. Carthew United Kingdom 28 571 0.9× 399 0.9× 406 1.6× 448 1.8× 190 0.8× 102 2.2k
Makoto Enomoto Japan 27 721 1.1× 501 1.1× 72 0.3× 127 0.5× 295 1.2× 109 2.5k
Arthur D. Bloom United States 21 578 0.9× 718 1.6× 155 0.6× 271 1.1× 111 0.5× 43 1.6k
Dawn G. Goodman United States 16 388 0.6× 281 0.6× 137 0.5× 214 0.9× 134 0.6× 27 1.4k
Mark Steven Miller United States 25 1.1k 1.7× 604 1.3× 263 1.0× 242 1.0× 510 2.1× 97 2.2k
Michael R. Elwell United States 27 426 0.6× 477 1.1× 116 0.4× 569 2.3× 209 0.9× 88 2.4k
T Sugimura Japan 24 1.7k 2.5× 879 1.9× 329 1.3× 202 0.8× 691 2.8× 64 3.7k
Ih‐Chang Hsu United States 23 1.3k 2.0× 776 1.7× 132 0.5× 177 0.7× 826 3.4× 51 2.8k

Countries citing papers authored by Robert A. Squire

Since Specialization
Citations

This map shows the geographic impact of Robert A. Squire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Squire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Squire more than expected).

Fields of papers citing papers by Robert A. Squire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Squire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Squire. The network helps show where Robert A. Squire may publish in the future.

Co-authorship network of co-authors of Robert A. Squire

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Squire. A scholar is included among the top collaborators of Robert A. Squire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Squire. Robert A. Squire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kroes, R., Ernst J. Schaefer, Robert A. Squire, & Gary M. Williams. (2003). A review of the safety of DHA45-oil. Food and Chemical Toxicology. 41(11). 1433–1446. 61 indexed citations
2.
Wu, Chuanchu, et al.. (1996). The use of 212Pb-labeled monoclonal antibody in the treatment of murine erythroleukemia. International Journal of Radiation Oncology*Biology*Physics. 34(3). 609–616. 38 indexed citations
3.
Maurer, James K., B.G. Boysen, Robert A. Squire, et al.. (1993). Confounded Carcinogenicity Study of Sodium Fluoride in CD-1 Mice. Regulatory Toxicology and Pharmacology. 18(2). 154–168. 14 indexed citations
4.
Carlo, George L., Philip Cole, Anthony B. Miller, et al.. (1992). Review of a study reporting an association between 2,4-dichlorophenoxyacetic acid and canine malignant lymphoma: Report of an expert panel. Regulatory Toxicology and Pharmacology. 16(3). 245–252. 24 indexed citations
5.
Steinberg, Gary D., Charles B. Brendler, Tomohiko Ichikawa, Robert A. Squire, & John T. Isaacs. (1990). Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model.. PubMed. 50(20). 6668–74. 51 indexed citations
6.
Squire, Robert A.. (1989). The interpretation of equivocal or marginal animal carcinogenicity tests. Cell Biology and Toxicology. 5(4). 371–376. 4 indexed citations
7.
Squire, Robert A.. (1984). Carcinogenic potency and risk assessment. Food Additives & Contaminants. 1(2). 221–231. 1 indexed citations
8.
Squire, Robert A.. (1983). Response : Ranking Carcinogens for Regulation. Science. 219(4582). 238–238. 1 indexed citations
9.
Sheffield, W. D., Robert A. Squire, & John D. Strandberg. (1981). Cerebral Venous Thrombosis in the Rhesus Monkey. Veterinary Pathology. 18(3). 326–334. 12 indexed citations
10.
Becci, Peter J., Henry J. Thompson, Clinton J. Grubbs, et al.. (1978). Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.. PubMed. 38(12). 4463–6. 70 indexed citations
11.
Stinson, Sherman F., Robert A. Squire, & Michael B. Sporn. (1978). Pathology of Esophageal Neoplasms and Associated Proliferative Lesions Induced in Rats by <italic>N</italic>-Methyl-<italic>N</italic>-benzylnitrosamine. JNCI Journal of the National Cancer Institute. 61(6). 1471–5. 38 indexed citations
12.
Ulland, Borge M., et al.. (1977). A Carcinogenicity Assay of Mirex in Charles River CD Rats2. JNCI Journal of the National Cancer Institute. 58(1). 133–140. 34 indexed citations
13.
Sporn, Michael B., et al.. (1977). 13- cis -Retinoic Acid: Inhibition of Bladder Carcinogenesis in the Rat. Science. 195(4277). 487–489. 215 indexed citations
14.
Goodman, Dawn G., et al.. (1976). Suppression of autoimmunity in nzb mice with steroid‐sensitive x‐radiation‐sensitive syngeneic young thymocytes. Arthritis & Rheumatism. 19(6). 1347–1350. 12 indexed citations
15.
Squire, Robert A. & Morton Levitt. (1975). Report of a workshop on classification of specific hepatocellular lesions in rats.. PubMed. 35(11 Pt 1). 3214–23. 321 indexed citations
16.
Squire, Robert A., et al.. (1971). Comments on Treatment of Leukemia in the Cat. Journal of the American Veterinary Medical Association. 158(6). 1134–1136. 1 indexed citations
17.
Altman, Norman H. & Robert A. Squire. (1970). Diagnosis of Canine Lymphoma. Journal of the American Veterinary Medical Association. 157(11). 1676–1680. 2 indexed citations
18.
Fleischman, Robert W., et al.. (1968). PATHOLOGIC CONFIRMATION OF MALARIA (Plasmodium elongatum) IN AFRICAN PENGUINS (Spheniscus demersus). PubMed. 4(4). 133–135. 13 indexed citations
19.
Nathanson, Neal, et al.. (1967). Viral Hemorrhagic Encephalopathy of Rats. Science. 156(3773). 392–394. 14 indexed citations
20.
Carmichael, L. E., et al.. (1964). A Fatal Septicemic Disease of Infant Puppies Caused by Gytopathogenic Organisms with Characteristics of Mycoplasma. Experimental Biology and Medicine. 117(3). 826–833. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026